NautaDutilh assisted LUMICKS Technologies with its $93M Series D Financing

NautaDutilh assisted LUMICKS Technologies B.V. with its $93 million Series D financing round. The financing round was led by new investors Farallon Capital Management and Lauxera Capital Partners.

The round included investments by Softbank Vision, funds and accounts advised by T. Rowe Price Associates, Parian Global Management, Pura Vida Investments and Irving Investors and was backed by existing investor Gilde Healthcare and select members of LUMICKS' management team.

LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. These instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells.

For press release and media attention, please see:

LUMICKS Technologies - https://lumicks.com/lumicks-raises-93-million-in-series-d-financing/

FD - https://fd.nl/ondernemen/1380389/amsterdams-bedrijf-in-kankeronderzoek-…

NautaDutilh's team consisted of Paul van der Bijl, Ruud Smits, Sanne Meester, Leanne Meurs, Joppe Schoute and Daan Hagelstein.

Related articles

NautaDutilh represents Uber with its investment in Moove's Series B round

ONWARD Medical completes accelerated bookbuild offering

NautaDutilh assists Blossom Capital with Series A+ investment in TheyDo

NautaDutilh assists NewAmsterdam Pharma with underwritten offering

NautaDutilh advises the Bellon family on the spin-off of Pluxee from Sodexo and its listing on Euronext Paris

NautaDutilh advises a.s.r. on its sale of Knab to BAWAG

Digital general meeting of legal entities under Private Law Act

NautaDutilh assist Pharvaris with underwritten offering

Life Sciences challenges and opportunities in Europe and the USA: key insights

US clawback rules for US-listed Dutch companies

NautaDutilh advises Merus on its USD 173 million follow-on offering of common shares

NautaDutilh advises MCAA on business combination with FC Barcelona’s content creation platform

Shareholder Activism & Engagement Guide 2023

NautaDutilh advises a.s.r. on its proposed business combination with Aegon Nederland

NautaDutilh advises Next.e.GO on its USD 913 million business combination with Athena Consumer Acquisition Corp.

NautaDutilh advises NewAmsterdam Pharma on USD 726 million business combination with Frazier Lifesciences Acquisition Corp.

NautaDutilh advises Accell Group on public offer by KKR-led consortium

NautaDutilh’s Dutch Capital Markets team involved in almost half of all 2021 Euronext IPOs

NautaDutilh assists SIGNA Sports United in de-SPAC transaction and NYSE listing

NautaDutilh advises German solar car company Sono Motors on its Nasdaq IPO

NautaDutilh assists sellers on the auction sale of Batavia Biosciences

NautaDutilh assists consortium led by Tencent on the listing of Universal Music Group

NautaDutilh advises Allego on its $3.14 billion business combination with Apollo-Affiliated Spartan Acquisition Corp. III

NautaDutilh advises SIGNA Sports United on its $3.2 billion business combination with Yucaipa

NautaDutilh assisted Ginkgo Bioworks on its acquisition of Dutch DNA Biotech

NautaDutilh assisted LAVA Therapeutics on its Nasdaq IPO

NautaDutilh assists AerCap Holdings N.V. with its acquisition of GE Capital Aviation Services (GECAS)

NautaDutilh assisted InflaRx N.V. on a fully underwritten follow-on offering

NautaDutilh assisted Pharming Group N.V. with the listing of its American Depositary Shares

NautaDutilh assisted Arvelle Therapeutics on its acquisition by Angelini Pharma

NautaDutilh assisted Pharvaris B.V. with its $80M Series C Financing

NautaDutilh assists Sanofi with public offer for Kiadis Pharma

NautaDutilh assisted the investor consortium led by Novo Holdings in a Series A financing round of The Protein Brewery

Vinted and United Wardrobe are joining forces. NautaDutilh assists Vinted with the acquisition of United Wardrobe

NautaDutilh assisted investor consortium including Novo Ventures in a $83 million Series C financing round by LAVA Therapeutics B.V.

Salvia Bioelectronics raises EUR 26 million from investor consortium

NautaDutilh assists CureVac on the private financing round, IPO and private placement

NautaDutilh successfully assisted VarmX in its EUR 32M oversubscribed Series B financing round

NautaDutilh assists Goldman Sachs in follow-on offering of Yandex

NautaDutilh assists BlueBee on its sale to Illumina Inc.

NautaDutilh advises Grubhub on its combination with Just Eat Takeaway.com

NautaDutillh assisted Forbion in a $62.5M Series A financing round by Prilenia Therapeutics B.V.

NECSTGEN: 4000 square meters for stem cell research, NautaDutilh advises.

Shareholder Activism & Engagement in The Netherlands and Luxembourg

NautaDutilh chairs Airbus annual general meeting in the midst of the coronavirus crisis

Government relief for start-ups and scale-ups

NautaDutilh advises Thermo Fisher on its public offer for QIAGEN

NautaDutilh assists Vopak and HAL with share buyback program NautaDutilh assists Vopak and HAL with share buyback program

NautaDutilh assists Pharming Group with its convertible bonds issue

Notification de cookies